title: Host genetic factors affect susceptibility to norovirus infections in Burkina Faso.
abstract: Norovirus (NoV) constitutes the second most common viral pathogen causing pediatric diarrhea after rotavirus. In Africa, diarrhea is a major health problem in children, and yet few studies have been performed regarding NoV. The association of histo-blood group antigens (HBGA) and susceptibility to NoV infection is well established in Caucasian populations with non-secretors being resistant to many common NoV strains. No study regarding HBGA and NoV susceptibility has yet been performed in Africa. We collected 309 stool and 208 saliva samples from diarrheal children in Ouagadougou, Burkina Faso; May 2009 to March 2010. NoV was detected using real-time PCR, and genotyped by sequencing. Saliva samples were ABO, Lewis and secretor phenotyped using in house ELISA assays. NoV was detected in 12% (n = 37) of the samples. The genotype diversity was unusually large; overall the 37 positive samples belonged to 14 genotypes. Only children <2 years of age were NoV positive and the GII.4 NoVs were more frequent in the late dry season (Jan-May). NoV infections were observed less in children with the secretor-negative phenotype or blood group A (OR 0.18; p = 0.012 and OR 0.31; p = 0.054; respectively), with two non-secretors infected with genotypes GII.7 and GII.4 respectively. Lewis-negative (Le(a-b-)) children, representing 32% of the study population, were susceptible to GII, but were not infected with any NoV GI. GII.4 strains preferentially infected children with blood group B whereas secretor-positive children with blood group O were infected with the largest variety of genotypes. This is the first study identifying host genetic factors associated with susceptibility to NoV in an African population, and suggests that while the non-secretor phenotype provides protection; the Lewis b antigen is not necessary for GII infection.
authors.affiliation: Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. johan.nordgren@liu.se
authors.forename: Johan
authors.initials: J
authors.lastname: Nordgren
authors.forename: Léon W
authors.initials: LW
authors.lastname: Nitiema
authors.forename: Djeneba
authors.initials: D
authors.lastname: Ouermi
authors.forename: Jacques
authors.initials: J
authors.lastname: Simpore
authors.forename: Lennart
authors.initials: L
authors.lastname: Svensson
mesh_terms: D000017:ABO Blood-Group System / Q000235:genetics; D000293:Adolescent; D000328:Adult; D001789:Blood Group Antigens / Q000235:genetics; D002050:Burkina Faso; D017250:Caliciviridae Infections / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D003967:Diarrhea / Q000097:blood / Q000453:epidemiology / Q000235:genetics; D005260:Female; D005759:Gastroenteritis / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D005838:Genotype; D054884:Host-Pathogen Interactions / Q000235:genetics; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007983:Lewis Blood Group Antigens / Q000235:genetics; D008297:Male; D008969:Molecular Sequence Data; D029322:Norovirus / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification; D010641:Phenotype; D010802:Phylogeny; D017361:Viral Nonstructural Proteins / Q000235:genetics; D055815:Young Adult
chemical_list: D000017:ABO Blood-Group System; D001789:Blood Group Antigens; D007983:Lewis Blood Group Antigens; D017361:Viral Nonstructural Proteins
references.citation: Lancet. 2010 Mar 13;375(9718):870-2
references.pmid: 19833382
references.citation: N Engl J Med. 2011 Dec 8;365(23):2178-87
references.pmid: 22150036
references.citation: J Infect Dis. 2005 Mar 1;191(5):749-54
references.pmid: 15688291
references.citation: J Med Virol. 2007 May;79(5):544-51
references.pmid: 17385696
references.citation: Emerg Infect Dis. 2012 Apr;18(4):589-97
references.pmid: 22469076
references.citation: Nat Rev Microbiol. 2010 Mar;8(3):231-41
references.pmid: 20125087
references.citation: Pediatr Infect Dis J. 2010 Oct;29(10):934-9
references.pmid: 20657344
references.citation: J Virol. 2005 Jun;79(11):6714-22
references.pmid: 15890909
references.citation: Virology. 2006 Mar 15;346(2):312-23
references.pmid: 16343580
references.citation: Rev Med Virol. 2011 Nov;21(6):370-82
references.pmid: 22025362
references.citation: J Med Virol. 2010 Feb;82(2):321-4
references.pmid: 20029818
references.citation: J Virol. 2005 Mar;79(5):2900-9
references.pmid: 15709009
references.citation: J Med Virol. 2008 Jul;80(7):1296-301
references.pmid: 18461617
references.citation: PLoS One. 2011;6(10):e25962
references.pmid: 22016794
references.citation: Emerg Infect Dis. 2010 Jun;16(6):980-2
references.pmid: 20507751
references.citation: Leg Med (Tokyo). 2001 Mar;3(1):2-14
references.pmid: 12935727
references.citation: J Clin Microbiol. 2003 Apr;41(4):1548-57
references.pmid: 12682144
references.citation: Emerg Infect Dis. 2008 Aug;14(8):1224-31
references.pmid: 18680645
references.citation: Emerg Infect Dis. 2010 Jan;16(1):81-7
references.pmid: 20031047
references.citation: Glycobiology. 2009 Mar;19(3):309-20
references.pmid: 19054801
references.citation: J Med Virol. 2006 Nov;78(11):1480-5
references.pmid: 16998875
references.citation: J Med Virol. 2007 Dec;79(12):1921-6
references.pmid: 17935183
references.citation: Emerg Infect Dis. 2005 Dec;11(12):1874-81
references.pmid: 16485473
references.citation: Nat Med. 2003 May;9(5):548-53
references.pmid: 12692541
references.citation: J Clin Microbiol. 2010 May;48(5):1943-6
references.pmid: 20305010
references.citation: Int J Infect Dis. 2011 Sep;15(9):e646-52
references.pmid: 21763172
references.citation: Scand J Infect Dis. 2011 Oct;43(10):804-8
references.pmid: 21696253
references.citation: PLoS One. 2013;8(3):e58605
references.pmid: 23472212
references.citation: J Clin Microbiol. 2008 Aug;46(8):2573-80
references.pmid: 18562593
references.citation: PLoS One. 2009;4(5):e5593
references.pmid: 19440360
references.citation: J Infect Dis. 2009 Sep 1;200(5):802-12
references.pmid: 19627248
references.citation: J Med Virol. 2011 Oct;83(10):1849-56
references.pmid: 21837804
references.citation: J Med Virol. 2012 Sep;84(9):1489-96
references.pmid: 22825829
references.citation: J Med Virol. 2009 Apr;81(4):728-35
references.pmid: 19235844
references.citation: Transfusion. 2009 May;49(5):959-66
references.pmid: 19175549
references.citation: J Clin Virol. 2010 Dec;49(4):258-64
references.pmid: 20869912
references.citation: J Virol. 2011 May;85(9):4057-70
references.pmid: 21345963
references.citation: J Med Virol. 2011 Dec;83(12):2135-42
references.pmid: 22012721
references.citation: J Clin Microbiol. 2008 Jan;46(1):164-70
references.pmid: 17959761
references.citation: Clin Infect Dis. 2012 Jul;55(2):189-93
references.pmid: 22491335
references.citation: J Clin Microbiol. 2007 Aug;45(8):2720-2
references.pmid: 17537929
references.citation: PLoS Med. 2008 Feb;5(2):e31
references.pmid: 18271619
references.citation: Vaccine. 2012 May 21;30(24):3580-6
references.pmid: 22469864
references.citation: J Virol. 2008 Nov;82(21):10756-67
references.pmid: 18701592
references.citation: Glycobiology. 2012 Sep;22(9):1163-72
references.pmid: 22589081
references.citation: J Clin Microbiol. 2008 Sep;46(9):2959-65
references.pmid: 18650354
references.citation: J Virol. 2005 Dec;79(24):15351-5
references.pmid: 16306606
references.citation: J Infect Dis. 2006 Nov 15;194(10):1422-7
references.pmid: 17054072
references.citation: J Med Virol. 2005 Dec;77(4):522-7
references.pmid: 16254959
references.citation: J Infect Dis. 2002 May 1;185(9):1335-7
references.pmid: 12001052
references.citation: Emerg Infect Dis. 2006 Oct;12(10):1536-41
references.pmid: 17176568